-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WRci6HAa417GQAEbM83LDMfbE5trM78QBurmZOoWFoRwBn5mSz3/PIx4Sl902LQd hn8ptg4WzhIp8YmE0N9+8A== 0001181971-08-000003.txt : 20080409 0001181971-08-000003.hdr.sgml : 20080409 20080409211015 ACCESSION NUMBER: 0001181971-08-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080407 FILED AS OF DATE: 20080409 DATE AS OF CHANGE: 20080409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOVENS DANIEL H CENTRAL INDEX KEY: 0001181971 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 08748701 BUSINESS ADDRESS: BUSINESS PHONE: 9544731027 MAIL ADDRESS: STREET 1: 11781 NW 9TH ST CITY: PLANTATION STATE: FL ZIP: 33325 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-04-07 0 0000887708 CARACO PHARMACEUTICAL LABORATORIES LTD CPD 0001181971 MOVENS DANIEL H 1150 ELIJAH MCCOY DRIVE DETROIT MI 48202 1 1 0 0 Chief Executive Officer Common Stock 2008-04-07 4 S 0 100 18.36 D 34900 D Common Stock 2008-04-07 4 S 0 400 18.4 D 34500 D Common Stock 2008-04-07 4 S 0 100 18.45 D 34400 D Common Stock 2008-04-07 4 S 0 200 18.49 D 34200 D Common Stock 2008-04-07 4 S 0 100 18.5 D 34100 D Common Stock 2008-04-07 4 S 0 200 18.51 D 33900 D Common Stock 2008-04-07 4 S 0 100 18.52 D 33800 D Common Stock 2008-04-07 4 S 0 218 18.53 D 33582 D Common Stock 2008-04-07 4 S 0 100 18.54 D 33482 D Common Stock 2008-04-07 4 S 0 300 18.55 D 33182 D Common Stock 2008-04-07 4 S 0 182 18.56 D 33000 D Common Stock 2008-04-07 4 S 0 19 18.59 D 32981 D Common Stock 2008-04-07 4 S 0 100 18.6 D 32881 D Common Stock 2008-04-07 4 S 0 100 18.62 D 32781 D Common Stock 2008-04-07 4 S 0 100 18.63 D 32681 D Common Stock 2008-04-07 4 S 0 200 18.65 D 32481 D Common Stock 2008-04-07 4 S 0 200 18.66 D 32281 D Common Stock 2008-04-08 4 S 0 100 17.82 D 32181 D Common Stock 2008-04-08 4 S 0 100 17.85 D 32081 D Common Stock 2008-04-08 4 S 0 100 17.87 D 31981 D Common Stock 2008-04-08 4 S 0 400 17.91 D 31581 D Common Stock 2008-04-08 4 S 0 200 17.96 D 31381 D Common Stock 2008-04-08 4 S 0 100 18.01 D 31281 D Common Stock 2008-04-08 4 S 0 100 18.05 D 31181 D Common Stock 2008-04-08 4 S 0 100 18.06 D 31081 D Common Stock 2008-04-08 4 S 0 380 18.1 D 30701 D Common Stock 2008-04-08 4 S 0 101 18.11 D 30600 D Common Stock 2008-04-08 4 S 0 300 18.16 D 30300 D Common Stock 2008-04-08 4 S 0 100 18.18 D 30200 D Common Stock 2008-04-08 4 S 0 200 18.45 D 30000 D On March 14, 2008, the reporting person entered into a Rule 10b5-1 trading plan to sell up to 30,000 shares of common stock for estate and tax planning objectives. The reported sales were effected pursuant to such Rule 10b5-1 plan. Fred B. Green as attorney-in-fact 2008-04-09 -----END PRIVACY-ENHANCED MESSAGE-----